DE2806909C2 - - Google Patents

Info

Publication number
DE2806909C2
DE2806909C2 DE2806909A DE2806909A DE2806909C2 DE 2806909 C2 DE2806909 C2 DE 2806909C2 DE 2806909 A DE2806909 A DE 2806909A DE 2806909 A DE2806909 A DE 2806909A DE 2806909 C2 DE2806909 C2 DE 2806909C2
Authority
DE
Germany
Prior art keywords
bis
trifluoromethyl
quinoline
methanol
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2806909A
Other languages
German (de)
English (en)
Other versions
DE2806909A1 (de
Inventor
Guenther North Caldwell N.J. Us Grethe
Toomas Bloomfield N.J. Us Mitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F HOFFMANN-LA ROCHE and Co AG BASEL CH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F HOFFMANN-LA ROCHE and Co AG BASEL CH filed Critical F HOFFMANN-LA ROCHE and Co AG BASEL CH
Publication of DE2806909A1 publication Critical patent/DE2806909A1/de
Application granted granted Critical
Publication of DE2806909C2 publication Critical patent/DE2806909C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19782806909 1977-02-17 1978-02-17 Verfahren zur herstellung von mefloquin Granted DE2806909A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76981677A 1977-02-17 1977-02-17

Publications (2)

Publication Number Publication Date
DE2806909A1 DE2806909A1 (de) 1978-08-24
DE2806909C2 true DE2806909C2 (sv) 1988-04-07

Family

ID=25086585

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782806909 Granted DE2806909A1 (de) 1977-02-17 1978-02-17 Verfahren zur herstellung von mefloquin

Country Status (9)

Country Link
JP (1) JPS53103478A (sv)
AT (1) AT358044B (sv)
BE (1) BE864002A (sv)
CH (2) CH640530A5 (sv)
DE (1) DE2806909A1 (sv)
FR (1) FR2381044A1 (sv)
GB (1) GB1594282A (sv)
IT (1) IT1158450B (sv)
NL (1) NL7801787A (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940443A1 (de) * 1979-10-05 1981-04-16 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von erythro-(alpha)-2-piperidyl-2,8-bis-(trifluormethyl)-4-chinolin-methanol
FR2485014A1 (fr) * 1980-06-20 1981-12-24 Pharmindustrie Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments
US4507482A (en) * 1982-04-14 1985-03-26 Hoffmann-La Roche Inc. Purification of mefloquin hydrochloride
DK160499C (da) * 1982-09-10 1991-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af mefloquin og mellemprodukt til anvendelse herved
JPH0234129U (sv) * 1989-05-25 1990-03-05
HUT54363A (en) * 1989-07-25 1991-02-28 Alkaloida Vegyeszeti Gyar Process for producing pyridyl-methyl-quinolin derivatives
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH590274A5 (sv) * 1970-03-16 1977-07-29 Hoffmann La Roche
CH605916A5 (sv) * 1973-12-07 1978-10-13 Hoffmann La Roche

Also Published As

Publication number Publication date
ATA113378A (de) 1980-01-15
FR2381044B1 (sv) 1983-06-10
CH640531A5 (en) 1984-01-13
NL7801787A (nl) 1978-08-21
CH640530A5 (en) 1984-01-13
IT1158450B (it) 1987-02-18
DE2806909A1 (de) 1978-08-24
IT7820331A0 (it) 1978-02-16
GB1594282A (en) 1981-07-30
FR2381044A1 (fr) 1978-09-15
JPS6257631B2 (sv) 1987-12-02
JPS53103478A (en) 1978-09-08
AT358044B (de) 1980-08-11
BE864002A (fr) 1978-08-16

Similar Documents

Publication Publication Date Title
DE2614406C2 (sv)
DE69303569T2 (de) Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer Darstellung
DD209622A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DE3010195C2 (sv)
EP0496238A1 (de) Substituierte Benzoxazepine und Benzthiazepine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE2806909C2 (sv)
DE2741233A1 (de) Verfahren zur herstellung von methoxypsoralen
DD229126A5 (de) Verfahren zur herstellung von tetronsaeure
EP0019172A1 (de) 6-Substituierte 11-Alkylen-morphantridine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
CH639639A5 (en) Alpha-fluoromethyl-alpha-amino-alkanoic acids and their esters
EP0428939B1 (de) Cumarinderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und Thiazolyl-essigsäurederivate als Zwischenprodukte
DE3825368A1 (de) Benzazepinderivate
DE2522314A1 (de) In 2-stellung substituierte dimethoxyindazole
DD219765A5 (de) Verfahren zur herstellung von substituierten hexahydropyrrolo (-1,2-a)-chinolin-, hexahydro-1h-pyrido (1,2-a)chinolin-, hexahydrobenzo(e)inden- und octahydrophenanthren-zns-mitteln
DE3300522C2 (sv)
CH653996A5 (de) Tryptaminderivate und verfahren zu deren herstellung.
CH635834A5 (de) Dibenzo(d,g)(1,3,6)dioxazocin-derivate, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittelpraeparate.
EP0019157A1 (de) 5,6-Dihydro-11-alkylen-morphantridin-6-one und Verfahren zu ihrer Herstellung
DE1695963A1 (de) Cycloalkenamin-p-benzochinonaddukte und Verfahren zu ihrer Herstellung
DE2834312C2 (de) Verfahren zur Herstellung von 2[N-(2-Hydroxyäthyl)-N-niederalkylaminomethyl]-benzhydrolen
EP0180890B1 (de) Verfahren zur diastereoselektiven Reduktion von 3-Amino-1-benzoxepin-5(2H)-onen
DD273250A5 (de) Verfahren zur herstellung von alpha-(1-methylethyl)-3,4-dimethoxybenzolacetonitril
DE3906460C1 (sv)
EP0650966A1 (de) Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
AT278775B (de) Verfahren zur Herstellung von Δ<2>-Imidazolinderivaten und ihren Salzen

Legal Events

Date Code Title Description
OB Request for examination as to novelty
OC Search report available
8110 Request for examination paragraph 44
8181 Inventor (new situation)

Free format text: GRETHE, GUENTHER, NORTH CALDWELL, N.J., US MITT, TOOMAS, BLOOMFIELD, N.J., US

D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8328 Change in the person/name/address of the agent

Free format text: LEDERER, F., DIPL.-CHEM. DR., 8000 MUENCHEN RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING., PAT.-ANWAELTE, 8300 LANDSHUT

8339 Ceased/non-payment of the annual fee